A cis-trans interaction at the 3'-untranslated region of ribonucleotide reductase mRNA is regulated by TGF-beta 1, TGF-beta 2, and TGF-beta 3.
The R2 component of ribonucleotide reductase is rate-limiting for DNA synthesis in proliferating cells, and recently, it has been shown that aberrant expression of R2 directly alters the malignant potential of tumor cells. We show that R2 gene expression is elevated in BALB/c 3T3 cells treated with transforming growth factor (TGF)-beta 1, TGF-beta 2, or TGF-beta 3, as determined by Northern blot analysis. Gel shift assays and UV crosslinking studies demonstrated similar post-transcriptional regulation at the 3'-untranslated region (3'-UTR) of the R2 mRNA, by TGF-beta 1, TGF-beta 2, and TGF-beta 3. The three growth factors induced a common 75 kDa RNA-protein complex. A 9 nucleotide sequence, GAGUUUGAG, previously shown to be responsive to TGF-beta 1-mediated R2 message stability changes, effectively competed out the formation of the R2 3'-UTR complex. We propose that these three different members of the TGF-beta family work through a common mechanism to control an important component of cell proliferation and a potential determinant of malignant progression.
Amara
F M
FM
Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada.
Smith
G M
GM
Kuschak
T I
TI
Takeuchi
T L
TL
Wright
J A
JA
D016475:3T3 Cells; D000818:Animals; D015152:Blotting, Northern; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D051379:Mice; D012333:RNA, Messenger / Q000096:biosynthesis / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D012264:Ribonucleotide Reductases / Q000096:biosynthesis*; D014158:Transcription, Genetic / Q000187:drug effects*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D012264:Ribonucleotide Reductases